Image of Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation

LITERATURE

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation


The RESTORE study, a multi-national randomized, placebo-controlled study, showed that erdosteine – a muco-active antioxidant that modulates bacterial adhesiveness – reduced the rate and duration of exacerbations in moderate and severe COPD with a history
of exacerbations. How much benefit patients with less severe disease experience when taking this drug remains unclear


Availability

Vectrine-006Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
International Journal of Chronic Obstructive Pulmonary Disease 2019:14 2733–2744
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous